Health tech startup Temple, founded by Eternal CEO Deepinder Goyal, has acquired London-based longevity medicine practice Longevous as it builds its clinical and scientific capabilities ahead of its wearable launch. The financial terms of the acquisition have not been disclosed.
Goyal announced the acquisition in a post on X, saying, “Temple is acquiring Longevous, an evidence-based longevity medicine practice based in London.” As part of the acquisition, Longevous founders Dr Robert Mohr and Dr Avi Roy, along with their team, will join Temple full time.
Temple acquires London-based Longevous
Hello everyone, quick update on @temple
We are excited to share that Temple is acquiring Longevous, an evidence-based longevity medicine practice based in London. The founders, Rob and Avi, and their team are joining Temple full time. They…
— Deepinder Goyal (@deepigoyal) August 27, 2026
Mohr will take charge as Chief Medical Officer, while Roy will become Temple’s Head of Science. Goyal said, “Dr. Robert Mohr joins Temple as Chief Medical Officer” and “Dr. Avi Roy joins as Head of Science at Temple.”
Temple Prepares For Wearable Launch
Temple is developing a compact wearable designed to sit on the temple area of the head. The device is intended to continuously track cerebral blood flow and oxygenation levels in real time, with the company building an in-house science team around the technology.
Goyal said Mohr and Roy began testing the device for around two months after meeting him at a dinner in London. According to his post, “For the next two months, they wore Temple as their daily driver for tracking all their activities.” He added that they “pressure tested Entropy and the data that Temple can collect, with our science team.”
Their involvement later extended into Temple’s validation work, with Goyal saying, “They challenged our assumptions and poked holes in our vision.” He also said they “have even reviewed our first scientific manuscripts before submission.”
Longevous Founders Take On Temple Roles
Mohr brings nearly two decades of experience across emergency and longevity medicine, while Roy is an Oxford-trained biomedical scientist with experience in longevity science and business.
Longevous will continue operating as part of Temple, with the practice retaining its existing operations and client base. Mohr and Roy will continue to personally look after Longevous clients alongside their new responsibilities at Temple.
FAQs
- What is Temple by Deepinder Goyal?
Temple is Deepinder Goyal’s health tech startup developing a wearable focused on tracking health and longevity-related data.
- What is the Deepinder Goyal Temple Longevous acquisition?
Temple has acquired London-based longevity medicine practice Longevous to strengthen its clinical and scientific capabilities ahead of its wearable launch.
- What is Longevous?
Longevous is a London-based longevity medicine practice focused on evidence-based approaches to health and longevity.
- Why did Temple acquire Longevous?
The acquisition brings clinical and scientific expertise into Temple as it works toward launching its wearable device.
